Gut Permeability and Microbiota in Parkinson’s Disease: Mechanistic Insights and Experimental Therapeutic Strategies

Globally, Parkinson’s disease (PD) is the neurodegenerative condition with the most rapidly increasing prevalence, and a growing body of evidence associates its pathology with impairments in the gut–brain axis. Traditionally viewed as a disease marked by the loss of dopaminergic neurons, emerging ev...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of molecular sciences Jg. 26; H. 19; S. 9593
Hauptverfasser:	Liang, Yicheng, Zhao, Yuhang, Fasano, Alessio, Su, Chien-Wen
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Switzerland MDPI AG 01.10.2025
Schlagworte:	alpha-Synuclein - metabolism Animals Blood-Brain Barrier - metabolism Celiac disease Cytokines Development and progression Fatty acids Gastrointestinal Microbiome - physiology Gluten Gut microbiota Health aspects Homeostasis Humans Hypotheses Inflammation Kinases Metabolites Microbiota (Symbiotic organisms) Neurodegeneration Neurons Parkinson Disease - metabolism Parkinson Disease - microbiology Parkinson Disease - therapy Parkinson's disease Pathogens Pathology Patients Peptides Permeability Proteins Stem cells Toxins Type 2 diabetes Massachusetts gut permeability neuroinflammation Parkinson’s disease (PD) leaky gut therapeutic approaches gut microbiota personalized therapy
ISSN:	1422-0067, 1661-6596, 1422-0067
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!